Cardinal Health CEO Mason sells $6.1m in shares

Published 20/08/2025, 00:38
Cardinal Health CEO Mason sells $6.1m in shares

Stephen M. Mason, CEO of the GMPD Segment at Cardinal Health INC (NYSE:CAH), a prominent healthcare services provider with a market capitalization of $35.6 billion, sold a total of 42,635 common shares on August 19, 2025, at prices ranging from $147.87 to $149.39, for a total value of $6,187,063. According to InvestingPro analysis, the company currently appears undervalued based on its Fair Value estimate.

According to a Form 4 filing with the Securities and Exchange Commission, Mason also disposed of 30,811 shares on August 15, 2025, to cover tax obligations, with the transaction valued at $4,628,428, at a price of $150.22. The stock has shown strong performance, delivering a 38% return over the past year, while maintaining a relatively low volatility profile with a beta of 0.68.

On the same date, Mason acquired 8,957 shares of Cardinal Health INC, with a value of $0. These shares were granted as restricted share units that will vest in three equal annual installments beginning on August 15, 2026.

Following these transactions, Mason directly owns 26,085 shares of Cardinal Health INC.

In other recent news, Cardinal Health reported its fourth-quarter earnings for fiscal 2025, revealing a mixed performance. The company achieved earnings per share (EPS) of $2.08, slightly exceeding the expected $2.03. However, revenue came in at $60.2 billion, falling short of the forecasted $60.92 billion. Additionally, Cardinal Health announced a $1 billion notes offering in two tranches, with $600 million in 4.500% notes due in 2030 and $400 million in 5.150% notes due in 2035. This offering was underwritten by Goldman Sachs & Co. LLC, BofA Securities, Inc., and Wells Fargo (NYSE:WFC) Securities, LLC. Furthermore, the company’s Board of Directors approved a quarterly dividend of $0.5107 per share, payable to shareholders of record as of October 1, 2025. These developments reflect Cardinal Health’s recent strategic and financial activities.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.